Department of Medicine

BASHAR KAHALEH RECENT PUBLICATIONS

2011-2010

Margheri F, Serratì S, Lapucci A, Chillà A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12. Arthritis Rheum. 2010 Aug;62(8):2488-98.

Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK 3rd, Impens AJ, Phillips K, Kahaleh B, Seibold JR, Koch AE. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther. 2011 Feb 8;13(1):R18.

Walker KM, Pope J. Scleroderma Clinical Trials Consortium; Canadian Scleroderma Research Group.   Alkassab F, Molitor JA, Shapiro LS, Fessler BJ, Gran JT, Goldberg A, Medsger TA Jr, Valentini G, Rodriguez-Reyna TS, Csuka ME, Griffing L, Herrick A, Connolly MK, Vacca A, Riemekasten G, Wigley FM, Farge D, Johnson SR, Matucci-Cerinic M, Czirjak L, Toloza SM, Mahmud TH, Frech TM, Voskuyl AE, Merkel PA, Domsic R, Emery P, Steen V, Rudnicka L, Denton CP, Clements PJ, Chatterjee S, Kahaleh B, Hayat S, Mouthon L, Lafyatis R, Lally EV, Krieg T, Chung L, Catoggio LJ, Mayes MD, Anderson ME, Silver R, Proudman S, Seibold JR, Senécal JL, Stevens W, Hachulla E, Inanc M, Wollheim F, Distler O, Katsumoto TR, Hsu V, Collier DH, Furst D, McKown K, Khanna D, Volkov S, Mathieu A, Baron M, Kaminska EA, Khalidi NA, Hudson M, Markland J, Masetto A, Docherty P. Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis. J Rheumatol. 2011 Jul;38(7):1326-8.

Wang Y, Kahaly O, Kahaleh B. Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Scleroderma Endothelial Cells by Targeting DNA Methyltransferase 1. Presented at the Annual American College of Rheumatology Meeting, Atlanta, GA, Nov 2010.

Altorok N, Kahaly O, Kahaleh B. “Systemic Sclerosis with vascular emphasis.” Inflammatory Diseases of Blood Vessels, 2nd edition.  Wiley-Blackwell. In press.

Kahaleh B, Mulligan-Kehoe M. “The Vascular Disease in Scleroderma.” Scleroderma: from pathogenesis to comprehensive management. In press.

2010-2009

Elkareh J, Periyasamy SM, Shidyak A, Vetteth S, Schroeder J, Raju V, Hariri IM, El-Okdi N, Gupta S, Fedorova L, Liu J, Fedorova OV, Kahaleh MB, Xie Z, Malhotra D, Watson DK, Bagrov AY, Shapiro JI. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy.  Am J Physiol Renal Physiol. 2009 May;296(5):F1219-26 

Margheri F, Serratì S, Lapucci A, Chillà A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M. Modulation of the angiogenic phenotype of normal Systemic Sclerosis endothelial cells by gain-loss of function of PTX3 MMP12. Arthritis Rheum. 2010 Apr 19. [Epub ahead of print]

Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A,

 

 

 

Last Updated: 6/27/22